Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.73 $595,933 - $986,906
172,235 New
172,235 $885,000
Q1 2022

May 16, 2022

SELL
$4.42 - $7.0 $329,192 - $521,346
-74,478 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$6.23 - $10.24 $463,997 - $762,654
74,478 New
74,478 $491,000

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $32.5M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Velan Capital Investment Management LP Portfolio

Follow Velan Capital Investment Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Velan Capital Investment Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Velan Capital Investment Management LP with notifications on news.